Israel's RealView Imaging Ltd. has received FDA 510(k) clearance for its HOLOSCOPE-i holographic system, the Yokneam-based company announced Monday.
Follow Israel Hayom on Facebook and Twitter
The system creates spatially accurate, three-dimensional interactive medical holograms, based on data received from standard CT scans and 3D ultrasound systems. The HOLOSCOPE-i is the first and only medical holography system which provides physicians with a natural 3D visualization experience, allowing direct and precise interaction with dynamic holograms of the patient's true anatomy, floating in free space at hand's reach, prior to and during interventional procedures.
Earlier this year the company, founded by Aviad Kaufman, Shaul Gelman and Prof. Carmel Rotschild, with a seed investment led by Dr. Shimon Eckhouse, expanded its series C financing round to $15 million.
"There is a rapidly growing need for advanced visualization solutions in the world of Medical Imaging, driven by the huge trend to perform minimally-invasive procedures that exclusively rely on imaging technologies," said Gelman. "The HOLOSCOPE-i delivers the next-generation of 3D interactive visualization tools that empower imaging-based medical interventions, allowing clinicians to intuitively understand the complex anatomy they are treating in a realistic and accessible way like never seen before."
Eckhouse, who serves as chairman of the board of directors of RealView, said, "Following this important FDA clearance, we are now focused on the commercialization of the HOLOSCOPE-i system in North America and are planning to expand our market reach to additional countries over the next year. I believe RealView can significantly impact the growing field of structural heart interventions, as well as additional clinical fields which rely on advanced imaging to deliver better and faster medical care."
